News Mylan finalises $465m deal with US government over EpiPen Mylan finalises rebate deal with US government.
News Biosimilars manufacturers close in on Roche cancer blockbust... FDA panel backs Herceptin and Avastin biosimilars.
News Mylan/Biocon Herceptin biosimilar faces EU delay EU inspectors require re-inspection of Bangalore plant.
News BMS's Breyanzi is first CAR-T for marginal zone lymphoma Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
